Lenvatinib Mesylate
Generic Name: lenvatinib mesylate
Dosage form: POWDER. Active ingredients: LENVATINIB MESYLATE (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: LENVATINIB MESYLATE (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Anti Aging Powder
anti aging powder
Amino Acid Hypertonic Solution [EPC]
Purpose Promote skin health Regulate the immune system
Abrotanum (artemisia Abrotanum), Aethusa Cynapium, Baptisia Tinctoria, Cicuta Virosa, Cuprum Metallicum, Mezereum, Bufo Rana, Lac Materna Humanum, Saccharum Officinale, Serotonin (hydrochloride), Alumina, Calcarea Phosphorica, Candida Albicans, Carcinosin, Lac Caninum, Mercurius Solubilis, Natrum Muriaticum, Propionic Acid, Sulphur, Thuja Occidentalis, Formalinum, Morbillinum
abrotanum (artemisia abrotanum), aethusa cynapium, baptisia tinctoria, cicuta virosa, cuprum metallicum, mezereum, bufo rana, lac materna humanum, saccharum officinale, serotonin (hydrochloride), alumina, calcarea phosphorica, candida albicans, carcinosin, lac caninum, mercurius solubilis, natrum muriaticum, propionic acid, sulphur, thuja occidentalis, formalinum, morbillinum
Non-Standardized Fungal Allergenic Extract [EPC]
PURPOSE: May temporarily relieve symptoms of dullness with gastro-intestinal discomfort, feeling unconnected to others, and minor symptoms following vaccination.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Tarlatamab-dlle
tarlatamab-dlle
11 DESCRIPTION Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dlle is produced using recombinant DNA technology in Chinese hamster ovary cells. It consists of 982 amino acids and has a molecular weight of approximately 105 kilodaltons.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.